We recently announced that the new ALBA Elution Kit was CE marked.

We are pleased to announce that Alba by Quotient continues to grow in Europe. It is now also available in the Czech Republic.

We are delighted to announce that the new ALBA Elution Kit is now CE mark

We are excited to announce that our abstract, titled “Performance characteristics of a new, fully automated planar microarray immunoassay for the detection of autoantibodies against Centromere Protein B and correlations wit

Quotient and FAS Diagnostic Group, Inc. have signed a distribution agreement, which will enable FAS Diagnostic Group, Inc.

We are excited to announce that we are in Bangkok, Thailand, from 16-18 August for Medlab Asia.

We are pleased to announce the next chapter of our exciting journey as a disruptive innovator in clinical diagnostics: Quotient is becoming AliveDx.

We are excited to announce that our abstract has

We are pleased to announce that we have successfully passed the annual ISO 14001 Surveillance Audit for our Eysins site in Switze

Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and Mo